2023-Oct-04

Investor Relations News QIII 2023

Financing Round Continues, Development in Duchenne Muscular Dystrophy (DMD), MetrioPharm Company Calendar H2, MetrioPharm informs

more...

2023-Jul-04

Investor Relations News QII 2023

MetrioPharm AG has started a new financing round, 17th Annual General Meeting of MetrioPharm AG, Company Calendar, MetrioPharm informs

more...

2023-Mar-30

Investor Relations News QI 2023

Invitation to a Webinar, Company Calendar, MetrioPharm informs

more...

2022-Dec-22

Investor Relations News QIV 2022

more...

2022-Oct-12

Investor Relations News QIII 2022

MetrioPharm at BioPharm America in Boston, USA, Company Calendar in QIV 2022, MetrioPharm blog, MetrioPharm at Linkedin

more...

2022-Jun-30

Investor Relations News QII 2022

16th Annual General Meeting of MetrioPharm AG, Bio-Europe Spring in Basel, BIO International Convention in San Diego, Company Calendar, London-Paris in 24 hours, MetrioPharm AG informs

more...

2022-Mar-31

Investor Relations News QI 2022

Outlook by the Chairman of the Board Rudolf Stäger

more...

2021-Dec-21

Investor Relations News QIV 2021

Greetings from CEO Thomas Christély

more...

2021-Oct-01

Investor Relations News QIII 2021

Topics: Greetings from CEO Thomas Christély, MetrioPharm in the Media

more...

2021-Jun-30

Investor Relations News QII 2021

Topics: 15th Annual General Meeting of MetrioPharm AG, MetrioPharm in the Media

more...